Xenon Pharmaceuticals Inc Discussion of XEN1101 and the Focal Epilepsy Landscape Transcript
Welcome to the Xenon Pharmaceuticals Investor Webinar. This call is being webcast live on the Investors section of Xenon's website at xenon-pharma.com. This broadcast is property of Xenon Pharmaceuticals and recording, reproduction or transmission of this call without the express written consent of Xenon is strictly prohibited. Please note this call is being recorded.
I would now like to introduce Ian Mortimer, President and CEO at Xenon Pharmaceuticals, who will act as a moderator of today's event. Ian?
Thanks, Jodi, and good morning, everyone. Thanks for joining us today on our webinar. Before we begin, I'll point out that we will be making some forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please consult the risk factors discussed in the press release
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |